Glen Nuckolls, Ph.D. is a Program Director (PD) in the Neurogenetics Cluster/Division of Neuroscience and is the NINDS point of contact regarding research on the causes and treatments of the muscular dystrophies, spinal muscular atrophy and inherited and acquired peripheral neuropathies. He is the Executive Secretary of the interagency Muscular Dystrophy Coordinating Committee, the programmatic lead for the Senator Paul D. Wellstone Muscular Dystrophy Research Centers and serves on the Programmatic Panel for the Duchenne Muscular Dystrophy program of the Congressionally Directed Medical Research Programs, Department of Defense. He also serves as the point of contact for the NINDS Rare Disease Clinical Trial Readiness program and participates in trans-NIH activities including the Rare Disease Clinical Research Network. Prior to joining NINDS, Dr. Nuckolls was the PD for muscle disorders and therapies at the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a Review Officer at NIAMS, and he conducted research on cartilage biology, skeletal development and osteoarthritis in the Intramural Programs of NIAMS. Dr Nuckolls completed his postdoctoral training in biochemistry at Stanford University and graduate training in cell biology and anatomy at the University of North Carolina, Chapel Hill.